I 
116TH CONGRESS 
2D SESSION 
H. R. 7025 
To amend the Public Health Service Act to authorize grants to certain 
public health laboratories to assist such laboratories in meeting the 
cost of acquiring high-throughput diagnostic equipment, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 27, 2020 
Mr. BUCSHON introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to authorize grants 
to certain public health laboratories to assist such labora-
tories in meeting the cost of acquiring high-throughput 
diagnostic equipment, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Diagnostic Testing for 
Public Health Labs Act of 2020’’. 
VerDate Sep 11 2014 
18:57 Jun 17, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7025.IH
H7025
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 2. GRANTS FOR PUBLIC HEALTH LABORATORIES TO 
ACQUIRE 
HIGH-THROUGHPUT 
DIAGNOSTIC 
EQUIPMENT. 
Section 2821 of the Public Health Service Act (42 
U.S.C. 300hh–31) is amended— 
(1) by redesignating subsection (b) as sub-
section (c); 
(2) in subsection (c), as so redesignated— 
(A) by redesignating paragraphs (1), (2), 
and (3) as subparagraphs (A), (B), and (C), re-
spectively, and moving the margin of each such 
redesignated subparagraph 2 ems to the right; 
and 
(B) by striking ‘‘There are authorized to 
be appropriated to carry out this section’’ and 
inserting the following: 
‘‘(1) IN GENERAL.—There are authorized to be 
appropriated to carry out subsection (a)’’; 
(3) by inserting after subsection (a) the fol-
lowing new subsection: 
‘‘(b) GRANTS FOR PUBLIC HEALTH LABORATORIES 
TO ACQUIRE HIGH-THROUGHPUT DIAGNOSTIC EQUIP-
MENT.— 
‘‘(1) GRANTS.—The Secretary, acting through 
the Director of the Centers for Disease Control and 
Prevention, shall award grants to eligible entities to 
VerDate Sep 11 2014 
18:57 Jun 17, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7025.IH
H7025
pamtmann on DSKBC07HB2PROD with BILLS
assist such entities in purchasing high-throughput 
diagnostic equipment and related supplies. 
‘‘(2) ELIGIBILITY.—To be eligible for a grant 
under paragraph (1), an entity shall— 
‘‘(A) be— 
‘‘(i) a State, local, or Tribal public 
health laboratory; 
‘‘(ii) a laboratory within a public 
health laboratory network coordinated or 
managed by the Centers for Disease Con-
trol and Prevention; 
‘‘(iii) a laboratory not described in 
clause (i) or (ii) that the Secretary deter-
mines (at the Secretary’s discretion) pro-
vides population-based testing for the pre-
vention and control of infectious, commu-
nicable, genetic, or chronic diseases; or 
‘‘(iv) a consortium of 2 or more enti-
ties described in any of clauses (i) through 
(iii); and 
‘‘(B) submit to the Secretary an applica-
tion at such time, in such manner, and con-
taining such information as the Secretary may 
reasonably require. 
VerDate Sep 11 2014 
18:57 Jun 17, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H7025.IH
H7025
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(3) 
USE
OF
FUNDS.—Amounts 
received 
through a grant under this subsection shall be used 
to purchase high-throughput diagnostic equipment 
and such materials as are necessary to administer, 
store, and process applicable tests, including diag-
nostic and serological tests. 
‘‘(4) AMOUNT OF GRANT.—The amount of a 
grant under paragraph (1) may not exceed 
$2,000,000, except in the case of eligible entity de-
scribed in paragraph (2)(A)(iv). 
‘‘(5) HIGH-THROUGHPUT
DIAGNOSTIC
EQUIP-
MENT DEFINED.—In this subsection, the term ‘high- 
throughput diagnostic equipment’ means legally- 
marketed equipment and supplies capable of per-
forming multichannel analysis for use in clinical lab-
oratory diagnostic testing.’’; and 
(4) by adding at the end of subsection (c), as 
redesignated, the following new paragraph: 
‘‘(2) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(A) IN
GENERAL.—For the purpose of 
carrying out subsection (b), there is authorized 
to be appropriated $250,000,000 for fiscal year 
2020, to remain available until expended. 
‘‘(B) ADMINISTRATIVE EXPENSES.—Of the 
amount made available to carry out subsection 
VerDate Sep 11 2014 
18:57 Jun 17, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7025.IH
H7025
pamtmann on DSKBC07HB2PROD with BILLS
(b) for any fiscal year, the Secretary may not 
use more than 5 percent of such amount for the 
expenses of administering subsection (b).’’. 
Æ 
VerDate Sep 11 2014 
18:57 Jun 17, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H7025.IH
H7025
pamtmann on DSKBC07HB2PROD with BILLS